Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells (Q43061115)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 May 2010
edit
Language Label Description Also known as
English
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells
scientific article published on 17 May 2010

    Statements

    Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells (English)
    Robert H Vonderheide
    Patricia M LoRusso
    Magi Khalil
    Elaina M Gartner
    Divis Khaira
    Denis Soulieres
    Prudence Dorazio
    Jennifer A Trosko
    Jens Rüter
    Gabriella L Mariani
    Tiziana Usari
    17 May 2010
    3485-3494

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit